• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性颅内高压(IIH)治疗中脑脊液压力开放的作用。

The role of opening CSF pressure in response to treatment for idiopathic intracranial hypertension (IIH).

机构信息

Tehran University of Medical Sciences, Headache Department, Iranian Center of Neurological Research, Tehran, Iran.

Tehran University of Medical Sciences, Headache Department, Iranian Center of Neurological Research, Tehran, Iran.

出版信息

J Clin Neurosci. 2020 Jun;76:171-176. doi: 10.1016/j.jocn.2020.04.066. Epub 2020 Apr 21.

DOI:10.1016/j.jocn.2020.04.066
PMID:32331944
Abstract

The aim of the current study was to assess the risk factors, clinical symptoms and Cerebrospinal fluid (CSF) pressure of idiopathic intracranial hypertension (IIH) with emphasis on determining the risk factors which involved in poor response to treatment. We retrospectively included 202 patients who were diagnosed with IIH. Disease severity was classified according to prescribed therapeutic option into 4 groups: acetazolamide (group 1), Acetazolamide plus topiramate or Lasix (group 2), repeated LP (group 3) and surgical intervention (group 4). Being in the higher group was considered as a higher severity of disease and poor response to treatment. Among the evaluated features of IIH, the strongest association were observed between opening CSF pressure and disease severity. So that, the highest CSF pressure was observed in patients who underwent surgery, which represent the highest severity of disease (group 4) and poor response to therapy (mean ± SD: 43.9 ± 21.1 cm HO). Headache was the most prevalent symptom of IIH in our series which was significantly higher among acetazolamide group. Blurred vision was the second most common symptoms which, unlike the headache was more reported in surgery group. Our results suggested that higher CSF pressure could be the risk factors of poor response to therapy, which may raise need for more intensive treatment. Furthermore, suffering of headache without blurred vision can consider as a prognostic factor for mild severity and good response to treatment.

摘要

本研究旨在评估特发性颅内高压(IIH)的危险因素、临床症状和脑脊液(CSF)压力,重点确定与治疗反应不佳相关的危险因素。我们回顾性纳入了 202 例确诊为 IIH 的患者。根据规定的治疗选择,将疾病严重程度分为 4 组:乙酰唑胺(第 1 组)、乙酰唑胺加托吡酯或速尿(第 2 组)、重复腰椎穿刺(第 3 组)和手术干预(第 4 组)。处于较高组被认为是疾病严重程度较高和治疗反应不佳。在评估的 IIH 特征中,与疾病严重程度相关性最强的是开放 CSF 压力。因此,在接受手术的患者中观察到最高的 CSF 压力,这代表了最高的疾病严重程度(第 4 组)和治疗反应不佳(平均 ± 标准差:43.9 ± 21.1 cm HO)。头痛是我们系列中 IIH 最常见的症状,在乙酰唑胺组中更为明显。视力模糊是第二常见的症状,与头痛不同,它在手术组中更为常见。我们的结果表明,较高的 CSF 压力可能是治疗反应不佳的危险因素,这可能需要更强化的治疗。此外,无视力模糊的头痛可能是轻度严重程度和良好治疗反应的预后因素。

相似文献

1
The role of opening CSF pressure in response to treatment for idiopathic intracranial hypertension (IIH).特发性颅内高压(IIH)治疗中脑脊液压力开放的作用。
J Clin Neurosci. 2020 Jun;76:171-176. doi: 10.1016/j.jocn.2020.04.066. Epub 2020 Apr 21.
2
Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial.特发性颅内高压性头痛:来自特发性颅内高压治疗试验的结果
Headache. 2017 Sep;57(8):1195-1205. doi: 10.1111/head.13153. Epub 2017 Jul 28.
3
[Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide].[托吡酯成功治疗1例对乙酰唑胺难治的特发性颅内高压]
No To Hattatsu. 2017 May;49(3):207-10.
4
Diagnosis and treatment of idiopathic intracranial hypertension (IIH) in children and adolescents.儿童和青少年特发性颅内高压的诊断和治疗。
Curr Neurol Neurosci Rep. 2013 Mar;13(3):336. doi: 10.1007/s11910-012-0336-x.
5
Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review.是否应将托吡酯作为特发性颅内高压治疗的初始治疗方法?:文献综述。
Medicine (Baltimore). 2023 Oct 20;102(42):e35545. doi: 10.1097/MD.0000000000035545.
6
The blurred vision mystery. Idiopathic intracranial hypertension.视力模糊之谜。特发性颅内高压。
Postgrad Med. 1998 Apr;103(4):101-2. doi: 10.3810/pgm.1998.04.454.
7
CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.特发性颅内高压治疗试验中的脑脊液压力、视乳头水肿分级及对乙酰唑胺的反应
J Neurol. 2015 Oct;262(10):2271-4. doi: 10.1007/s00415-015-7838-9. Epub 2015 Jul 10.
8
Secondary Intracranial Hypertension in Pediatric Patients With Leukemia.小儿白血病患者的继发性颅内压升高。
Pediatr Neurol. 2017 Dec;77:48-53. doi: 10.1016/j.pediatrneurol.2017.08.013. Epub 2017 Sep 1.
9
Transverse sinus stenoses persist after normalization of the CSF pressure in IIH.在IIH患者中,脑脊液压力正常后,横窦狭窄仍然存在。
Neurology. 2005 Oct 11;65(7):1090-3. doi: 10.1212/01.wnl.0000178889.63571.e5.
10
Paediatric idiopathic intracranial hypertension.小儿特发性颅内高压
BMJ Case Rep. 2013 Jan 24;2013:bcr2012007578. doi: 10.1136/bcr-2012-007578.

引用本文的文献

1
Effectiveness of Topiramate Versus Acetazolamide in the Management of Idiopathic Intracranial Hypertension: ASystematic Review and Meta-Analysis.托吡酯与乙酰唑胺治疗特发性颅内高压的疗效:一项系统评价和荟萃分析
Medicina (Kaunas). 2025 Mar 4;61(3):450. doi: 10.3390/medicina61030450.